Search results
Results from the WOW.Com Content Network
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
It is the N-ethyl analog of 1,3-benzodioxolylpentanamine (BDP; K). Ethyl-K was first synthesized by Alexander Shulgin. In his book PiHKAL ("Phenethylamines i Have Known And Loved"), the minimum dosage is listed as 40 mg and the duration is unknown. [1] [2] Very little is known about the pharmacology, pharmacokinetics, effects, and toxicity of ...
1-Aminopentane is an organic compound with the formula CH 3 (CH 2) 4 NH 2. It is used as a solvent , as a raw material in the manufacture of a variety of other compounds, including dyes, emulsifiers , and pharmaceutical products, [ 1 ] and as a flavoring agent .
Common side effects of the inhaled form include wheezing, cough, and nausea. [1] It is unclear if doses should be changed in those with kidney or liver problems. [1] Pentamidine is not recommended in early pregnancy but may be used in later pregnancy. [1] Its safety during breastfeeding is unclear. [3]
SR9009, also known as Stenabolic, is a research drug that was developed by professor Thomas Burris of the Scripps Research Institute as an agonist of Rev-ErbA (i.e., increases the constitutive repression of genes regulated by Rev-ErbA) [1] with a half-maximum inhibitory concentration (IC 50) = 670 nM for Rev-ErbAα and IC 50 = 800 nM for Rev-ErbAβ. [2]
Triethylenetetramine (TETA and trien), also known as trientine when used medically, is an organic compound with the formula [CH 2 NHCH 2 CH 2 NH 2] 2. The pure free base is a colorless oily liquid, but, like many amines, older samples assume a yellowish color due to impurities resulting from air oxidation. It is soluble in polar solvents.
Eutylone (also known as β-keto-1,3-benzodioxolyl-N-ethylbutanamine, bk-EBDB, and N-ethylbutylone) is a stimulant and empathogenic drug of the phenethylamine, amphetamine, phenylisobutylamine, and cathinone families which was developed in the 1960s, [3] [4] which is classified as a designer drug. [5]
[10] [14] It is far less potent as an antagonist of the dopamine D 1, D 3, and D 5 receptors (IC 50 = 3,200–8,300 nM) and of the serotonin 5-HT 2A receptor (IC 50 = 14,000 nM). [14] The drug does not significantly bind to or inhibit the α-adrenergic receptors , nor does it affect various other receptors , such as the serotonin 5-HT 1A , 5-HT ...